{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:41:14Z","timestamp":1774273274442,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"S3","license":[{"start":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T00:00:00Z","timestamp":1289433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Erythropoietic protoporphyria (EPP) is a hereditary disorder caused by deficiency of ferrochelatase, the last enzyme in the heme biosynthetic pathway. The majority of EPP patients present with a clinical symptom of painful phototoxicity. Liver damage, the most serious complication of EPP, occurs in &lt;5% of the patients. This report describes a case of an EPP patient who complained of worsening cutaneous symptoms, nervousness, and insomnia. Laboratory tests showed highly increased protoporphyrin concentration in erythrocytes and elevated serum transaminases that are indicative of EPP\u2010related liver damage. The subsequent finding of decreased serum thyroid\u2010stimulating hormone (TSH) and increased free triiodothyronine (FT3) and free thyroxine (FT4) concentrations, as well antibodies against both thyroid peroxidase (TPO) and TSH receptors, led to the diagnosis of Graves\u2019 disease. The patient received 500 MBq of radioiodine (I<jats:sup>131<\/jats:sup>). Three months after the radioactive iodine therapy, the thyroid volume was reduced to 30% of pretherapeutic volume. Although the patient was slightly hypothyroidic, his liver enzymes returned to normal, his erythrocytic protoporphyrin concentration dropped fivefold, and his skin symptoms improved dramatically. The coexistence of Graves\u2019 disease and EPP is a statistically rare event as, besides our patient, there was one additional case reported in the literature. Although the exact mechanism whereby Graves\u2019 disease interacts with EPP is yet to be explored, we recommend testing thyroid function in EPP patients with liver complication to exclude hyperthyroidism as a potential cause.<\/jats:p>","DOI":"10.1007\/s10545-010-9234-z","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T07:34:51Z","timestamp":1289374491000},"page":"465-469","source":"Crossref","is-referenced-by-count":6,"title":["Exacerbation of erythropoietic protoporphyria by hyperthyroidism"],"prefix":"10.1002","volume":"33","author":[{"given":"Elisabeth I.","family":"Minder","sequence":"first","affiliation":[{"name":"Central laboratory Triemli Hospital Zurich Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas R.","family":"Haldemann","sequence":"additional","affiliation":[{"name":"Institute for Nuclear Medicine Triemli Hospital Zurich Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoye","family":"Schneider\u2010Yin","sequence":"additional","affiliation":[{"name":"Central laboratory Triemli Hospital Zurich Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,11,11]]},"reference":[{"key":"e_1_2_4_2_1","first-page":"2991","volume-title":"The metabolic and molecular basis of inherited disease","author":"Anderson K","year":"2001"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.21.2.157"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.15.4291"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-7-6-687"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90093-4"},{"key":"e_1_2_4_7_1","first-page":"45","article-title":"Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria","volume":"55","author":"Delaby C","year":"2009","journal-title":"Cell Mol Biol (Noisy\u2010le\u2010grand)"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(89)80081-5"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.64.756.735"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-003-1059-5"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.1998.tb00011.x"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199704000-00013"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8182"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07472.x"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-088120"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-014142"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)92427-8"},{"key":"e_1_2_4_18_1","first-page":"91","article-title":"A genotype\u2010phenotype correlation between null\u2010allele mutations in the ferrochelatase gene and liver complication in patients with erythropoietic protoporphyria","volume":"48","author":"Minder EI","year":"2002","journal-title":"Cell Mol Biol (Noisy\u2010le\u2010grand)"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.06.178"},{"key":"e_1_2_4_20_1","first-page":"198","article-title":"Porphyria in Switzerland, 15 years experience","volume":"139","author":"Schneider\u2010Yin X","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"e_1_2_4_21_1","volume-title":"Erythropoietic protoporphyria, clinical and epidemiological aspects","author":"Wahlin S","year":"2010"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2008.08.003"},{"key":"e_1_2_4_23_1","first-page":"1171","article-title":"Erythropoietic protoporphyria associated with hyperthyroidism and jaundice","volume":"28","author":"Yamada K","year":"1971","journal-title":"Naika"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90068-P"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-010-9234-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T06:23:49Z","timestamp":1694759029000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-010-9234-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,11]]},"references-count":23,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1007\/s10545-010-9234-z"],"URL":"https:\/\/doi.org\/10.1007\/s10545-010-9234-z","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,11]]}}}